Alembic Pharmaceuticals

Last updated

Alembic Pharmaceuticals Ltd.
Company type Public
BSE:  533573
NSE:  APLLTD
Industry Pharmaceuticals
Founded1907 [1]
Headquarters
Vadodara, Gujarat [2]
,
India
Area served
Worldwide
Key people
 Chirayu Amin (Chairman)
Pranav Amin (MD)
Shaunak Amin (MD)
Products Pharmaceuticals, Branded and Generic drugs,
RevenueIncrease2.svg ₹ 31.31 billion (US$ 470.632 million) (2016-2017) [3]
Increase2.svg ₹ 4.01 billion (US$ 60.276 million) (2016-2017) [3]
Number of employees
9000+ (2017) [3]
Parent Alembic Group
Website www.alembicpharmaceuticals.com

Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara. [2] It is involved in the manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India. [2]

Contents

The company has its headquarters and corporate office situated in Vadodara, Gujarat, India, while its manufacturing facilities are located at Panelav, Karakhadi in Gujarat and Sikkim, India. [2] [4] Its Panelav plant houses active pharmaceutical ingredients (APIs) and formulation manufacturing, while its Sikkim plant is involved in manufacture of formulations for Indian and non-regulated export markets. [5]

History

Alembic Pharmaceuticals Ltd. initially began as Alembic Chemical Works where it started manufacturing tincture and alcohol at its unit at Vadodara in 1907. [1] The company eventually entered into manufacturing cough syrups, vitamins, tonics and sulphur drugs. [2] Further, Alembic entered into production of penicillin in the 1960s. [1] This dedicated Alembic plant for the manufacture of penicillin was inaugurated by Lal Bahadur Shastri in the year 1961, the then Prime Minister of India. [2] Alembic soon also initiated bulk production of vitamin B12. In the antibiotic section, soon after initiation of penicillin manufacture, Alembic began the production of erythromycin in 1971 for first time in India. Alembic also incorporated and launched the 'Althrocin' brand of erythromycin. In the year, 1997, Althrocin became the top selling brand of erythromycin in India.

In 2000, Alembic received ISO 14000 certification for its Vadodara facility. [2]

In 2010, Alembic Pharmaceutical Ltd. demerged from Alembic Ltd. subsequent to the allotment of 133,515,914 equity shares of ₹2 each to the shareholders of Alembic Ltd. This made the shareholding of Alembic Ltd. in Alembic Pharmaceutical reduce from 100% to 29.18%. [6]

In 2011, the equity shares of Alembic Pharmaceuticals Ltd. were listed on the Bombay Stock Exchange and National Stock Exchange of India. [6]

Products and services

Alembic manufactures and sells pharmaceutical and active pharmaceutical ingredients (APIs). [2] It also offers international and domestic formulations, with branded and generic formulations being under its domestic formulations. [5]

Research and development

Alembic has two research and development (R&D) centres which have been well supported by Alembic for its growth initiatives. The company has spent much of its capital on R&D, with majority of expenses on R&D for its markets in the US. [7] For the FY2015-2016, Alembic Pharmaceuticals invested ₹346 crore in R&D alone with 470 on-going projects. [3]

Mergers and acquisitions

Listing and shareholding

On 20 September 2011, [6] the equity shares of Alembic Pharmaceuticals post its demerger from Alembic Ltd. got listed on the Bombay Stock Exchange [10] where it is a constituent of BSE 500 index and on the National Stock Exchange of India [11] where it is a constituent of Nifty 500 index.

Awards and recognitions

See also

Related Research Articles

Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

<span class="mw-page-title-main">Biocon</span> Indian multinational biopharmaceutical company

Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.

<span class="mw-page-title-main">Eisai (company)</span> Japanese pharmaceutical company

Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Century Pharmaceuticals</span> Indian pharmaceutical company

Century Pharmaceuticals Ltd. is an Indian pharmaceutical company, founded in 1982 in Vadodara, Gujarat, India.

Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

<span class="mw-page-title-main">Sun Pharma</span> Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. 

<span class="mw-page-title-main">Vivimed Labs</span>

Vivimed Labs Limited is an India-based global supplier of specialty chemicals and pharmaceuticals. Headquartered in Hyderabad, India. Vivimed is a manufacturer of active pharmaceutical ingredients, active ingredients for home and personal care, hair dyes, imaging chemicals and photochromics.

<span class="mw-page-title-main">Lupin Limited</span> Indian multinational pharmaceutical company

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.

<span class="mw-page-title-main">Elder Pharmaceuticals</span> Indian pharmaceutical company

Elder Pharmaceuticals Ltd is a pharmaceutical company headquartered in Mumbai, Maharashtra. Its main activities include the manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices. Its largest presence in three therapeutic segments, Women's Healthcare, Wound Care and Nutraceuticals. It has 6 manufacturing plants in India & 1 in Nepal. It manufacture various dosage forms like tablets, capsules, syrups, injectables, topical creams and ointments.

Ajanta Pharma Limited, also known by the acronym APL, is a multinational company based in India engaged in development, manufacturing, and marketing of pharmaceutical formulations. It has a presence in India, the United States, and about 30 other countries in Africa, South East Asia, West Asia, and CIS. It was established in 1973.

Orchid Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992, by Kailasam Raghavendra Rao, an alumnus of IIM Ahmedabad. As of 2007, it was among the top fortune 500 Indian companies by market capitalization.

The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of APIs locally produced. Pakistani pharmaceutical companies are engaged in importing raw materials, compounding APIs with excipients, coating of pills, and fill-finish activities. The industry is regulated by the Drug Regulatory Authority of Pakistan, which oversees drug approvals and pricing.

<span class="mw-page-title-main">Aurobindo Pharma</span> Indian multinational pharmaceutical company

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.

Dishman Carbogen Amcis Ltd is an Indian multinational pharmaceutical company specialized in the manufacture of active ingredients and contract development and manufacturing. Dishman employs over 1,000 people worldwide and is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE).

Alembic Group is an Indian conglomerate headquartered in Vadodara. It was founded in 1907 and was initially known as Alembic Chemical Works Company Ltd. The company was founded by Prof. T.K. Gajjar, Prof. A.S. Kotibhasker and B.D. Amin. It is one of the oldest industrial houses in India and has a diversified portfolio of business. Their major businesses include, pharmaceuticals, healthcare, engineering, chemicals and glassware production. In 2014–2015, the market cap of Alembic Group was ₹9,578 crore while its turnover was ₹2,200 crore.

<span class="mw-page-title-main">Laurus Labs</span> Indian pharmaceutical company

Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients (APIs), generic formulations, custom synthesis (CDMO), biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.

<span class="mw-page-title-main">Natco Pharma</span> Indian pharmaceutical company

Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. NATCO is a science driven company and focuses on limited competition molecules in the US.

The Pharmaceutical industry in Gujarat ranks number one in India with a 33% share in drug manufacturing and a 28% share in drug exports. The state has 130 USFDA certified drug manufacturing facilities. Ahmedabad and Vadodara are considered as pharmaceutical hubs as there are many big and small pharma companies established in these cities.

References

  1. 1 2 3 "Pricing pressure: Alembic may exit penicillin-G business". Times of India. 27 February 2004. Retrieved 9 January 2017.
  2. 1 2 3 4 5 6 7 8 "Alembic Pharmaceuticals Ltd". profit.ndtv.com. Retrieved 26 December 2016.
  3. 1 2 3 4 "Annual Report 2016-17" (PDF). Archived from the original (PDF) on 17 November 2017. Retrieved 24 November 2017.
  4. ↑ "Alembic Pharmaceuticals". CNBC moneycontrol. Retrieved 3 January 2017.
  5. 1 2 "Alembic Pharmaceuticals receives FDA approval for hypertension tablets". RTN.Asia. 18 November 2016. Retrieved 3 January 2017.
  6. 1 2 3 4 5 6 7 "Alembic Pharmaceuticals". Business Standard. Retrieved 27 December 2016.
  7. ↑ "Alembic Pharma: Right prescription". The Hindu - BusinessLine. 20 August 2016. Retrieved 4 January 2017.
  8. ↑ "Alembic acquires Dabur's domestic non-oncology biz". The Hindu – BusinessLine. February 2007. Retrieved 9 January 2017.
  9. ↑ "Alembic acquires Non-Oncology Business of Dabur Pharma". CNBC moneycontrol. Retrieved 9 January 2017.
  10. ↑ "BSE India" . Retrieved 11 January 2017.
  11. ↑ "NSE India" . Retrieved 11 January 2017.
  12. ↑ "Forbes - Top 50 Companies 2016". Forbes. Retrieved 4 January 2017.
  13. ↑ "Thomas Reuters India InnovationAwards 2015" . Retrieved 4 January 2017.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.